CapsoVision (CV) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CapsoVision (CV) has outperformed Viemed Healthcare (VMD) over the past year, gaining 38.9% versus a gain of 36.4%. Viemed Healthcare is the larger company by market cap ($357.5 million vs $349.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | VMD |
|---|---|---|
| Share price | $6.57 | $9.39 |
| Market cap | $349.59M | $357.46M |
| 1-day change | +0.46% | +0.16% |
| YTD return | -38.82% | +26.11% |
| 1-year return | +38.85% | +36.39% |
| 5-year return | — | +62.39% |
| P/E ratio (TTM) | — | 26.07 |
| Forward P/E | — | 23.46 |
| EPS (TTM) | $-0.45 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.37 | $12.61 |
| 52-week low | $4.38 | $6.05 |
| Distance from 52-week high | -57.25% | -25.57% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +44.60% | +33.19% |
| Average volume | 158.10K | 354.36K |
| Shares outstanding | 53.21M | 38.09M |
| Employees | 99 | 1,438 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Health Care · Misc Health and Biotechnology Services · 1,438 employees
CV vs VMD FAQ
Which is bigger, CapsoVision or Viemed Healthcare?
Viemed Healthcare (VMD) is larger, with a market capitalization of $357.46M compared with $349.59M for CapsoVision (CV).
Which stock has performed better over the past year, CV or VMD?
CV returned +38.85% over the past 12 months, compared with +36.39% for VMD (price return, excluding dividends). Past performance does not predict future results.
Are CapsoVision and Viemed Healthcare in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CapsoVision and Misc Health and Biotechnology Services for Viemed Healthcare.